martindale.com
Legal Library
|
The Wrong Prescription? Revisiting the Justification for Poison Pills by Mark Lebovitch
Bernstein Litowitz Berger & Grossmann LLP - New York Office
Laura Gundersheim
Bernstein Litowitz Berger & Grossmann LLP - New York Office
|
|
September 11, 2009
Previously published by The Advocate for Institutional Investors, Third Quarter 2009 on October 2009
Based on massive value losses from withdrawn tender offers in the last few years, it may be time to revisit the broad judicial deference that has allowed directors to use poison pills to stand between
bidders and stockholders indefinitely.
|
The views expressed in this document are solely the views of the author and not Martindale-Hubbell. This document is intended for informational purposes only and is not legal advice or a substitute for consultation with a licensed legal professional in a particular case or circumstance. |
| | View More Library Documents By... | | | |
| | | | Bernstein Litowitz Berger & Grossmann LLP Overview |
Practice Area Resource Centers
|
|